SCHEMBL2185503

SCHEMBL2185503

Cc1ccc(-c2cc(C(=O)O)cc(-c3ncccn3)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 5/20 0.60
CTRC Q99895 1/20 0.51
FABP1 P07148 1/20 0.50
P2RY14 Q15391 1/20 0.50
RXRA P19793 1/20 0.50
RXRB P28702 1/20 0.50
MAP4K4 O95819 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
KAT6A Q92794 1/20 0.44
KDM5A P29375 2/20 0.44
KDM4C Q9H3R0 2/20 0.44
KDM5B Q9UGL1 2/20 0.44
KDM4A O75164 1/20 0.44
EGFR P00533 1/20 0.44
KMO O15229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17051406 0.86 CLK4 (0.45) DHODHALDH1A1KDM4EGAASLC6A7
SCHEMBL16196117 0.86 DHODH (0.70) DHODHCTRCFABP1P2RY14RXRA
SCHEMBL3474973 0.83 DHODH (0.59) DHODHCTRCFABP1P2RY14RXRA
SCHEMBL18311207 0.83 TPMT (0.57) DHODHCTRCRXRARXRBKAT6A
SCHEMBL1495453 0.82 DHODH (0.70) DHODHCTRCFABP1P2RY14RXRA
SCHEMBL29198735 0.80 DHODH (0.46) DHODHALDH1A1KDM4EMAPTKAT6A
SCHEMBL1495579 0.80 NPC1 (0.49) DHODHCTRCFABP1P2RY14RXRA
SCHEMBL2300946 0.80 MEN1 (0.45) ALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL406923 0.79 DHODH (0.51) DHODHCTRCFABP1P2RY14RXRA
SCHEMBL3718584 0.79 KDM4E (0.63) DHODHCTRCFABP1P2RY14RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133122-B2 Amide compounds, compositions and uses thereof EVOTEC AG (DE) 2015-09-15 US disclosed
US-20140323532-A1 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF EVOTEC AG (DE) 2014-10-30 US disclosed
EP-2346825-A2 MODULATORS OF P2X3 RECEPTOR ACTIVITY Evotec AG (DE) 2011-07-27 EP disclosed
WO-2010033168-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF RENOVIS, INC. (US) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323532-A1 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF IL1B, ADORA2B, AVPR1B DHODH 3626/4885CTRC 2925/4885FABP1 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.